BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23782471)

  • 21. Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) - protocol for prospective cohort study.
    Bogdanet D; O'Shea PM; Halperin J; Dunne F
    BMC Pregnancy Childbirth; 2020 Jul; 20(1):412. PubMed ID: 32682411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A culturally adapted lifestyle intervention addressing a Middle Eastern immigrant population at risk of diabetes, the MEDIM (impact of Migration and Ethnicity on Diabetes In Malmö): study protocol for a randomized controlled trial.
    Saha S; Leijon M; Gerdtham U; Sundquist K; Sundquist J; Arvidsson D; Bennet L
    Trials; 2013 Sep; 14():279. PubMed ID: 24006857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A complex behavioural change intervention to reduce the risk of diabetes and prediabetes in the pre-conception period in Malaysia: study protocol for a randomised controlled trial.
    Skau JK; Nordin AB; Cheah JC; Ali R; Zainal R; Aris T; Ali ZM; Matzen P; Biesma R; Aagaard-Hansen J; Hanson MA; Norris SA
    Trials; 2016 Apr; 17(1):215. PubMed ID: 27117703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The DIAMIND study: postpartum SMS reminders to women who have had gestational diabetes mellitus to test for type 2 diabetes: a randomised controlled trial - study protocol.
    Heatley E; Middleton P; Hague W; Crowther C
    BMC Pregnancy Childbirth; 2013 Apr; 13():92. PubMed ID: 23587090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gestational diabetes mellitus (Update 2023)].
    Kautzky-Willer A; Winhofer Y; Kiss H; Falcone V; Berger A; Lechleitner M; Weitgasser R; Harreiter J
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):115-128. PubMed ID: 37101032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atlantic DIP: high prevalence of abnormal glucose tolerance post partum is reduced by breast-feeding in women with prior gestational diabetes mellitus.
    O'Reilly MW; Avalos G; Dennedy MC; O'Sullivan EP; Dunne F
    Eur J Endocrinol; 2011 Dec; 165(6):953-9. PubMed ID: 21937504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIH consensus development conference: diagnosing gestational diabetes mellitus.
    Vandorsten JP; Dodson WC; Espeland MA; Grobman WA; Guise JM; Mercer BM; Minkoff HL; Poindexter B; Prosser LA; Sawaya GF; Scott JR; Silver RM; Smith L; Thomas A; Tita AT
    NIH Consens State Sci Statements; 2013 Mar; 29(1):1-31. PubMed ID: 23748438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of a customised mobile phone text messaging intervention supported by data from activity monitors for improving lifestyle factors related to the risk of type 2 diabetes among women after gestational diabetes: protocol for a multicentre randomised controlled trial (SMART MUMS with smart phones 2).
    Marschner S; Chow C; Thiagalingam A; Simmons D; McClean M; Pasupathy D; Smith BJ; Flood V; Padmanabhan S; Melov S; Ching C; Cheung NW
    BMJ Open; 2021 Sep; 11(9):e054756. PubMed ID: 34535488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression to type 2 diabetes mellitus after gestational diabetes mellitus diagnosed by IADPSG criteria: Systematic review and meta-analysis.
    Juan J; Sun Y; Wei Y; Wang S; Song G; Yan J; Zhou P; Yang H
    Front Endocrinol (Lausanne); 2022; 13():1012244. PubMed ID: 36277725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.
    Aroda VR; Christophi CA; Edelstein SL; Zhang P; Herman WH; Barrett-Connor E; Delahanty LM; Montez MG; Ackermann RT; Zhuo X; Knowler WC; Ratner RE;
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1646-53. PubMed ID: 25706240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IDEAL study: investigation of dietary advice and lifestyle for women with borderline gestational diabetes: a randomised controlled trial - study protocol.
    Crowther CA; Hague WM; Middleton PF; Baghurst PA; McPhee AJ; Tran TS; Yelland LN; Ashwood P; Han S; Dodd JM; Robinson JS;
    BMC Pregnancy Childbirth; 2012 Oct; 12():106. PubMed ID: 23046499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cluster-randomized controlled trial to study the effectiveness of a protocol-based lifestyle program to prevent type 2 diabetes in people with impaired fasting glucose.
    Hesselink AE; Bilo HJ; Jonkers R; Martens M; de Weerdt I; Rutten GE
    BMC Fam Pract; 2013 Dec; 14():184. PubMed ID: 24295397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus and abnormal glucose tolerance development after gestational diabetes: A three-year, prospective, randomized, clinical-based, Mediterranean lifestyle interventional study with parallel groups.
    Pérez-Ferre N; Del Valle L; Torrejón MJ; Barca I; Calvo MI; Matía P; Rubio MA; Calle-Pascual AL
    Clin Nutr; 2015 Aug; 34(4):579-85. PubMed ID: 25262459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial protocol.
    Norris SA; Zarowsky C; Murphy K; Ware LJ; Lombard C; Matjila M; Chivese T; Muhwava LS; Mutabazi JC; Harbron J; Fairall LR; Lambert E; Levitt N
    BMJ Open; 2024 Jan; 14(1):e073316. PubMed ID: 38195169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for type 2 diabetes: literature review and economic modelling.
    Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
    Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of a diabetes prevention program for rural women with prior gestational diabetes mellitus: study protocol of a multi-site randomized clinical trial.
    Guo J; Tang Y; Wiley J; Whittemore R; Chen JL
    BMC Public Health; 2018 Jun; 18(1):809. PubMed ID: 29954367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifestyle intervention programme for Indian women with history of gestational diabetes mellitus.
    Kapoor D; Gupta Y; Desai A; Praveen D; Joshi R; Rozati R; Bhatla N; Prabhakaran D; Reddy P; Patel A; Tandon N
    Glob Health Epidemiol Genom; 2019; 4():e1. PubMed ID: 30891248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and diagnosing gestational diabetes mellitus.
    Hartling L; Dryden DM; Guthrie A; Muise M; Vandermeer B; Aktary WM; Pasichnyk D; Seida JC; Donovan L
    Evid Rep Technol Assess (Full Rep); 2012 Oct; (210):1-327. PubMed ID: 24423035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2019 Flemish consensus on screening for overt diabetes in early pregnancy and screening for gestational diabetes mellitus.
    Benhalima K; Minschart C; Van Crombrugge P; Calewaert P; Verhaeghe J; Vandamme S; Theetaert K; Devlieger R; Pierssens L; Ryckeghem H; Dufraimont E; Vercammen C; Debie A; De Block C; Vandenberghe G; Van Imschoot S; Verstraete S; Buyse L; Wens J; Muyldermans J; Meskal A; De Spiegeleer S; Mathieu C
    Acta Clin Belg; 2020 Oct; 75(5):340-347. PubMed ID: 31259665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.